Lv41
422 积分 2023-09-07 加入
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
18分钟前
待确认
The Two Sides of Bispecific Antibodies in Multiple Myeloma: Where Trial Promise Meets Real-World Practice
18天前
已完结
ID2 suppresses multiple myeloma cell proliferation by repressing the activity of the transcription factor TCF3
30天前
已完结
ID2 suppresses multiple myeloma cell proliferation by repressing the activity of the transcription factor TCF3
1个月前
已关闭
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
2个月前
已完结
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins
2个月前
已完结
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network
2个月前
已完结
Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bi-Specific T-Cell Engaging Antibody in GBM via Passive and Active Mechanisms
3个月前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
3个月前
已完结
A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape
3个月前
已完结
皖公网安备34019202002308
